ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome

Clinical trial NCT02392572 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02392572
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Acute Lymphoblastic Leukemia Recurrent Acute Myeloid Leukemia Recurrent Myelodysplastic Syndrome Refractory Acute Lymphoblastic Leukemia Refractory Acute Myeloid Leukemia Refractory Myelodysplastic Syndrome

Start date: 2015-11-03
Primary completion: 2026-11-30
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.